Kairos Pharma (KAPA)

Profile

Full Name

Kairos Pharma

Ticker Symbol

KAPA

Country

United States

IPO

September 16, 2024

Indexes

Not included

Employees

-

Key Details

Price

$0.95(+4.73%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

-

Annual EPS

-$0.17(-70.00% YoY)

PE ratio

-

Next earnings date

Apr 21, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price Performance

Price Range

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Shares Outstanding

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

EPS

Profit

Expenses

EBIT & EBITDA

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Liabilities

Debt

Equity & Capital

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

CAPEX

Free Cash Flow

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

ROA & ROE

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Analyst ratings

Recent major analysts updates

Apr 3, 25 HC Wainwright & Co.
Buy
Mar 31, 25 D. Boral Capital
Buy
Mar 27, 25 Maxim Group
Buy
Mar 20, 25 D. Boral Capital
Buy
Feb 26, 25 D. Boral Capital
Buy
Feb 18, 25 D. Boral Capital
Buy
Feb 12, 25 D. Boral Capital
Buy
Jan 22, 25 D. Boral Capital
Buy
Nov 14, 24 D. Boral Capital
Buy
Oct 14, 24 EF Hutton
Buy

Institutional Ownership

  • What is the ticker symbol for Kairos Pharma?
  • Does Kairos Pharma pay dividends?
  • What sector is Kairos Pharma in?
  • What industry is Kairos Pharma in?
  • What country is Kairos Pharma based in?
  • When did Kairos Pharma go public?
  • Is Kairos Pharma in the S&P 500?
  • Is Kairos Pharma in the NASDAQ 100?
  • Is Kairos Pharma in the Dow Jones?
  • When was Kairos Pharma's last earnings report?
  • When does Kairos Pharma report earnings?
  • Should I buy Kairos Pharma stock now?

What is the ticker symbol for Kairos Pharma?

The ticker symbol for Kairos Pharma is NYSE American:KAPA

Does Kairos Pharma pay dividends?

No, Kairos Pharma does not pay dividends

What sector is Kairos Pharma in?

Kairos Pharma is in the Healthcare sector

What industry is Kairos Pharma in?

Kairos Pharma is in the Biotechnology industry

What country is Kairos Pharma based in?

Kairos Pharma is headquartered in United States

When did Kairos Pharma go public?

Kairos Pharma's initial public offering (IPO) was on September 16, 2024

Is Kairos Pharma in the S&P 500?

No, Kairos Pharma is not included in the S&P 500 index

Is Kairos Pharma in the NASDAQ 100?

No, Kairos Pharma is not included in the NASDAQ 100 index

Is Kairos Pharma in the Dow Jones?

No, Kairos Pharma is not included in the Dow Jones index

When was Kairos Pharma's last earnings report?

Kairos Pharma's most recent earnings report was on Nov 14, 2024

When does Kairos Pharma report earnings?

The next expected earnings date for Kairos Pharma is Apr 21, 2025

Should I buy Kairos Pharma stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page